A new study of the U.K. and South Africa variants of SARS-CoV-2 predicts that current vaccines and certain monoclonal antibodies may be less effective at neutralizing these variants.
A recent scientific paper by Columbia University scientists has highlighted the growth of a mutant strain of COVID-19 in New York City that appears to be partially resistant to vaccinations.
“We have basically been seeing viral evolution happen in front of our eyes for the past year and a half,” Dr. Ho says, director of the Aaron Diamond AIDS Research Center at Columbia University.
